1. 1135PDCharacterization of the immune tumor microenvironment (TME) to inform personalized medicine with immuno-oncology (IO) combinations. (23rd October 2018) Authors: Luke, J J; Edwards, R; Hedvat, C; Pandya, D; Ely, S; Meier, R; McDonald, D; Harbison, C T; Baxi, V; Lee, G; Szabo, P; Garcia, T; Bao, R; Reilly, T P; Jaffee, E; Hodi, F S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. (5th November 2018) Authors: Chan, T A; Yarchoan, M; Jaffee, E; Swanton, C; Quezada, S A; Stenzinger, A; Peters, S Journal: Annals of oncology Issue: Volume 30:Number 1(2019) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗